ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly improves disease ...

The traditional gold standard of clinical trials with a randomized, placebo-controlled design involving hundreds of patients ...

PHILADELPHIA, PA — Medicus Pharma Ltd. (Nasdaq: MDCX) recently submitted an updated Phase 2 clinical study design to the U.S.

Detailed price information for Fractyl Health Inc (GUTS-Q) from The Globe and Mail including charting and trades.

In dementia care relying only on randomized controlled trials can leave out a large amount of strong research that reflects ...

Mistletoe therapy may improve the QOL of patients with cancer; however, evidence does not support a survival benefit, ...

This reduces delays and improves results. For example, some platforms offer support for early-stage research and help teams ...

Across multiple studies, the motivation for using cannabis predicts outcomes as strongly as frequency of use. Among emerging ...

The more invasive segment 4b/5 resection did not improve overall or disease-free survival compared to wedge resection in gallbladder cancer. 2. Segment 4b/5 resection was associated with longer ...

Kalohexis, a clinical-stage biotechnology company harnessing the melanocortin system to shape the next era of metabolic disease care starting with obesity and cancer cachexia, today announced a poster ...

UAB is leading a national study examining how personalized genetic risk information can improve prevention of chronic ...

Latest stories about Social Media on Business Insider ...